CXMT’s claimed tech breakthrough and an AI industry leader’s comments are weighing on stocks across the sector.

The shares are currently undervalued as the market overstates how much GLP-1 weight-loss drugs will erode demand. Sleep ...

The bottom line: Our $44 fair value estimate for no-moat Woodside is little changed. At around $31.50, the market remains ...

A subtle shift is influencing who can borrow, how much they can access and which property strategies still stack up.

Shani and Mark explore the trade-offs investors face when choosing between income, growth and different investment strategies.

Many Australians already have infrastructure in their super. But does this listed infrastructure ETF offer the stability, ...

Mark LaMonica: Welcome to another edition of Market Minute. This week we have Matt here to take us through everything happening in markets. The firm’s IPO big news the IPO that now is not happening.

How investors can navigate a narrowing opportunity set in a risky environment through the remainder of the year.

Leading AI labs are building economic moats to stave off commodification threats.

This week’s insights come directly from the US Morningstar editorial team. Year to date performance of US tech stocks. Aussie investors are increasingly gaining exposure to US s ...

Under these reforms, the downside is there now appears less prospect of high after-tax gains. But on the upside, there is also less chance of large after-tax losses. So how investors will react to ...

Income on 20th of June 2026: This represents the dividends and distributions in the preceding 12 months on the 20th of June ...